EDUCATION
Attend a Workshop
Online corporate workshops are free to the public and valuable opportunities to learn from industry representatives and scientific experts about the latest advances and instrumentation relevant to molecular diagnostics and research.
They are a year-round extension of the popular corporate workshops presented each year at the AMP Annual Meeting & Expo.
Register for an upcoming workshop
Integrated DNA Technologies - Tuesday June 24, 2025 @ 2:00pm Eastern
Unlocking RNA Insights in Solid Tumors and Blood Cancers: Archer FUSIONPlex™ Technology for Fusion Detection and Beyond - A University of Iowa Perspective
Speaker:
Natalya Guseva, PhD, HCLD (ABB)
Technical Director, Molecular Pathology Laboratory
University of Iowa Health Care Medical Center
Moderator:
Emily Davis, MBA
Sr. Commercial Product Manager, NGS Solutions
Integrated DNA Technologies
Agilent - Tuesday July 29, 2025 @ 11:00am Eastern
Who Says You Can't Have It All: Rapid Comprehensive Molecular Profiling of Hematological Malignancies
Speaker:
Sean Glenn, PhD
Vice Chair, Molecular Pathology
Roswell Park Comprehensive Cancer Center
View an archived workshop
There is no fee or membership requirement to access archived presentations.
Invivoscribe - May 6, 2025
A Case for Precision MRD Assessments: Clonal Rearrangement Detection in Hematologic Malignancies
Speakers:
Yury Monczak, PhD
Assistant Professor
McGill University & University of Montreal
Canada
Affiliated with Jewish General Hospital and Montreal University Health Center (MUHC)
Moderated by:
Thomas Penny, PhD
Associate Director, Commercial Americas
Invivoscribe
Coming Soon
Thermo Fisher Scientific — March 11, 2025
A New Era in The Diagnostics of Acute Leukemia: Ultra-Rapid Molecular Testing in Academic and Community Hospital Settings
Speakers:
Valentina Nardi, M.D.
Associate Professor of Pathology, Harvard Medical School
Associate Director of Hematological Molecular Pathology, Mass General Brigham
Amir Fathi, M.D.
Leukemia Program, Director, Massachusetts General Hospital
Associate Professor of Medicine, Harvard Medical School
Anthony W.S. Chi, M.D., Ph.D.
Subchief of Hematopathology an Molecular Pathology
Regional Laboratory Rockville
Mid-Atlantic Permanente Medical Group
Kaiser Permanente Mid-Atlantic States
Pfizer — February 25, 2025
Biomarker Testing in Metastatic Colorectal Cancer (mCRC): BRAF Mutation Implications
Speaker:
Michelle Shiller, DO, AP, CP, MGP, FACP
Medical Director Cancer Genetics and Chair of the Quality Committee, Baylor Sammons Cancer Center
National Medical Director, Genomics and Molecular Pathology Services, PathGroup
Agilent — January 28, 2025
Moving Past Panels: Somatic Exomes and Transcriptomes in an Academic Medical Center
Speaker:
Parth Shah, M.D.
Director of Genomic Informatics
Assistant Professor of Pathology and Laboratory Medicine
Dartmouth
Thermo Fisher Scientific — December 11, 2024
Prevalence of blood-based biomarkers determined by liquid biopsy molecular testing in the community setting in the United States: a focus on NSCLC
Speaker:
Gary Pestano, Ph.D.
Chief Development Officer
Biodesix
Colorado, USA
Illumina — November 6, 2024
Comprehensive Genomic Testing and Targeted Therapies in NSCLC and Thyroid Cancer Patients with Gene Fusions
Speaker:
James Solomon, M.D., Ph.D.
Assistant Professor
Department of Pathology and Laboratory Medicine
Weill Cornell Medical College
IntegratedDNA Technologies — October 2, 2024
Genomic Profiling of Haematological Malignancies using Archer NGS Panels - the HSL Experience
Speaker:
Robert Baker, BSc, MSc
Molecular Haematology Operations Manager
Health Service Laboratories
Moderator:
Elina Wegner, B.Sc., M.Sc.
Director, Custom NGS Products
Integrated DNA Technologies
Invivoscribe Inc. — September 17, 2024
Innovations in MRD Detection: Leveraging NGS to Gain Insights into Multiple Myeloma and B-ALL
Speakers:
Roisin McAvera, BSc (Hons), Ph.D.
Multiple Myeloma Research Group
Royal College of Surgeons in Ireland
Prof. Myungshin Kim
Dept. Laboratory Medicine, College of Medicine
The Catholic University of Korea
Moderator:
Parth Sitlani
Associate Director, Commercial EMEA/APAC
Invivoscribe Inc.
Handouts: LymphoTrack Assay - MiSeq | LymphoTrack Assay - Ion S5
Invivoscribe — March 20, 2024
Level Up Your MRD Testing: Leveraging Standardized & Sensitive AML Assessments
Speakers:
Speakers: Tony Sanchez, M.D.
Technical Account Manager
Josh Wemmer, M.S.
Sr. Bioinformatician
Illumina — December 5, 2023
Comprehensive Genomic Testing and Targeted Therapies in NSCLC and Thyroid Cancer Patients with Gene Fusions
Speakers:
Lori Wirth, MD
Medical Director, Center for Head and Neck Cancers
Massachusetts General Hospital
Carlo Bifulco, MD
Chief Medical Officer
Providence Genomics
This corporate workshop is also supported by Bayer.
Integrated DNA Technologies — November 7, 2023
Comprehensive, Reliable Answers for Heme Malignancies with Customized Archer™ NGS assays
Speakers:
Barbara Anderson, PhD, MB (ASCP)CM
Analytical Specialist
Division of Molecular Pathology, Genetics and Genomics
Duke University Health System
Ludmila Francescatto, PhD
Laboratory Genetics & Genomics Fellow
Division of Molecular Pathology, Genetics and Genomics
Duke University Health System
Invivoscribe — May 31, 2023
NGS Assessment of SHM in CLL/SLL: A Practical Comparison of Platforms & Primers
Speaker:
Kseniya Petrova–Drus, MD, PhD
Assistant Attending Pathologist
Hematopathology and Diagnostic Molecular Pathology
Memorial Sloan Kettering
Asuragen — January 12, 2023
Diverse Data Matters: Implementing a Simple Yet Comprehensive PCR/CE Based CFTR Kit
Speaker:
Andrea Ferreira–Gonzalez, PhD HCLD(ABB), CC(ABB), FACC
Professor and Chair, Division Molecular Diagnostics
Director, Molecular Diagnostics Laboratory
Virginia Commonwealth University
Moderator:
Ninad Pendsé, MS, MBA
Senior Product Manager
Asuragen, a Bio-Techne Brand
Invivoscribe — November 15, 2022
Lab Secrets: NGS-based MRD Testing for Acute Lymphoblastic Leukemia - the Austin Experience
Rishu Agarwal, MBBS PhD FRCPA
Molecular Haematologist
Austin Health & Peter MacCallum Cancer Center
Melbourne, Australia
Stephen B. Ma, BbiomedSc BSc (Hon) MD DipMus LMusA (dist)
Laboratory Haematology Registrar
Austin Health
Melbourne, Australia
QIAGEN — August 31, 2022
Xerna TME™ Panel: An RNA-Based Investigational Assay Designed to Predict Patient Response to Anti-Angiogenic and Immune Targeted Therapies
Speaker:
Mark Uhlik
Vice President,
Head of Research & Biomarker Discovery
OncXerna Therapeutics
QIAGEN — August 23, 2022
Faster, simpler, more efficient: The latest improvements in NGS workflows for targeted DNA sequencing
Speakers:
Krishna Amin
Senior Global Product Manager, Targeted NGS
QIAGEN
Sophie Fiola
Field Application Scientist, Clinical Customers
QIAGEN Diagnostics
Janssen — July 14, 2022
Precision Medicine: Exon 20 Marks the Spot — EGFR Exon 20 Mutations in Non-Small Cell Lung Cancer (NSCLC)
Speakers:
Hatim Husain, MD
Associate Professor of Medicine
University of California, Moores Cancer Center
Eric Vail, MD
Director, Molecular Pathology
Assistant Professor, Pathology & Laboratory Medicine
Cedars–Sinai Medical Center
Genentech — June 15, 2022
Medicare Coverage of Next Generation Sequencing: Pulling Back the Curtain on the What, Why, & How of Medicare Coverage Testing
Speaker:
Gabriel Bien–Willner, MD, PhD, FCAP
Medical Director of MolDX
Chief Medical Officer, Palmetto GBA
Invivoscribe — February 24, 2022
Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS)
Speakers:
Riccardo Bomben, MD
Clinical & Experimental Onco–Hematology Unit
IRCCS CRO Aviano, Italy
Wouter De Brouwer, MD
Vrije Universiteit Brussel (VUB)
Universitaire Ziekenhuis Brussel
Department of Hematology
Brussels, Belgium
Handouts:
Invivoscribe MRD Software
Invivoscribe Study of MRD
Lympho Track — MiSeq Workflow
Lympho Track S5PGM Workflow
Takeda — January 27, 2022
EGFR Exon 20 Insertions: Distinct EGFR Mutations in NSCLC with Practical Application
Speakers:
Dr. Michelle Shiller, DO, MSPT
Co-Medical Director, Cancer Genetics
Baylor University Medical Center
Dr. Tarek Mekhail, MD
Medical Director, Thoracic Cancer Program
AdventHealth Cancer Institute
Asuragen — December 9, 2021
Practical and Reliable CFTR Variant Detection for Diverse Populations with the AmplideX® PCR/CE CFTR Kit
Speaker:
John Milligan, PhD
Senior Manager, R&D, Asuragen
Invivoscribe — October 28, 2021
Explore the Benefits, Considerations, and Utility of NGS B- and T-cell Clonality Testing
Speakers:
B. Melody Zhang, MD, MS, FCAP, A(ACHI)
Stanford University, School of Medicine
Bijal A Parikh, MD, PhD
Washington University School of Medicine
IDT — September 22, 2021
IDT GMP and OEM Capabilities
Speakers:
Mitch Gore
Commercial & Technical Manager for the B2B, qPCR, and Custom Oligo Product Lines
IDT
Renee Rathjen
GMP Product Manager
IDT
QIAGEN — August 25, 2021
Ultra-sensitive NGS-based Liquid Biopsy Technology in Companion Diagnostics
Speakers:
Frederick S. Jones, PhD
Senior Director, Life Science Medical Affairs
Sysmex Inostics
Johannes Fredebohm, PhD
Head of Research and Innovation
Sysmex Inostics
Dr. Reinhard Ortmann
Director Companion Diagnostics
QIAGEN
QIAGEN — May 27, 2021
The COVID-19 Challenge: The Diagnostic Laboratory Experience
Speakers:
Heba Mostafa, MD, PhD
Johns Hopkins
Jason Ong
Senior Director Marketing, NeuMoDx
Amgen — April 28, 2021
KRAS G12C — A Key Emerging Biomarker in the Pathogenic Evaluation of NSCLC
Speaker:
Pranil K. Chandra, DO, FCAP, FASCP
Chief Medical Officer of Genomic and Clinical Pathology
Pathgroup
Illumina — March 31, 2021
Testing Methodologies for Optimal Identification of Rare Fusion Events
Speaker:
Susan Hsiao, MD, PhD
Assistant Professor of Pathology & Cell Biology
Columbia University
AstraZeneca — February 24, 2021
A Multidisciplinary Approach for Patients with Resectable NSCLC
Speaker:
Shirley Michelle Shiller, DO, MSPT
Co-Director, Medical Genetics; Staff Pathologist
Baylor Sammons Cancer Center, Baylor University Medical Center
Dallas, TX
Bristol Myers Squibb — December 16, 2020
Translatability of Tumor Inflammation Gene Signatures & Blood-Based Biomarkers of Immuno-Oncology
Speakers:
Nancy Zhang, MD
Associate Director, Pharmacodiagnostics and Precision Medicine, BMS
Jonathan Baden
Senior Director Pharmacodiagnostic, BMS
Canaxia Health — November 4, 2020
Treating Late Stage Cancer Patients During a Pandemic: An International and Multidisciplinary Perspective
Presenters:
David Huntsman, MD, FRCPC, FCCMG
Chew Wei Memorial Professor of Gynaecologc Oncology,
Professor: Departments of Pathology and Laboratory Medicine and Obstetrics and Gynaecology: UBC (CANADA)
William G. Morice, II, M.D., Ph.D.
Chair of the Department of Laboratory Medicine and Pathology
President of Mayo Labs Rochester, MN, (U.S.A)
Joerg Kriegsmann
Medical Director of Sonic Germany, aka Molecular Pathologie Trier, (GERMANY)
Rosalyn Juergens, B.S. (Hons), MD., PhD
Associate Professor, Department of Oncology, McMaster University
Adjunct Assistant Professor, Department of Oncology, The Johns Hopkins Medical Institute (CANADA).
AstraZeneca — July 29, 2020
Liquid Biopsy Testing Strategies for Patients with Metastatic NSCLC
Presenter:
John W. Longshore, PhD, FACMG
Director, Molecular Pathology Laboratory
Atrium Health, formerly Carolinas HealthCare System
Carolinas Pathology Group
Charlotte, North Carolina
QIAGEN — June 26, 2020
Tackling COVID-19 through Syndromic Testing – QIAstat-Dx Respiratory SARS-CoV-2 Panel
Presenter:
Davide Manissero, MD, MRCPCH, MSc, DTM&H
VP, Head of Medical Affairs & Chief Medical Officer
Infection & Immune Diagnostics, QIAGEN
AstraZeneca — May 28, 2020
Molecular Testing for Alterations in DNA Damage Repair Pathway Genes in Ovarian & Prostate Cancer: Why, Who, & How to Test
Presenter:
Samuel Caughron, MD, FCAP
Pathologist, President & CEO, MAWD Pathology Group
Chair of Pathology & Medical Director of Clinical Laboratory, Advent Health Kansas City
QIAGEN — May 12, 2020
Learn how to implement a streamlined, single NGS workflow for the analysis of DNA and RNA – all from a single sample
Presenter:
Sylvia Herold, PhD
Institut für Pathologie
Universitätsklinikum Dresden
Bristol Myers Squibb — April 9, 2020
Current and Emerging Biomarkers: Science, Technology, & Practicalities
Presenter:
Tabetha Sundin, PhD, HCLD (ABB), MB(ASCP)
Scientific Director
Molecular Diagnostics & Serology
Sentara Healthcare
INVIVOSCRIBE — February 27, 2020
Utility of NGS Assays for the Evaluation of Lymphoid Malignancies
Presenters:
Yury Monczak, PhD, Scientific Co-Director, Molecular Pathology Center, McGill University Health Center, Jewish General Hospital, Assistant Professor, McGill University
Bevan Tandon MD, Director, Cancer Genomics, BioReference Laboratories, an OPKO Health Company
HOLOGIC — January 30, 2020
New Tools to Overcome Challenges in Vaginitis Diagnosis and Treatment
Presenter: Jane Schwebke, MD, Professor of Medicine – Infectious Disease Division, University of Alabama–Birmingham
QIAGEN — December 18, 2019
The Power of ONE: Introducing a Novel 1-Day Workflow for Simultaneous High-Sensitivity Analysis of DNA Variants & RNA Fusions
Presenter:Jonathan Shaffer, PhD, MBA, Associate Director, NGS Assay Research & Development, QIAGEN
QIAGEN — December 12, 2019
Experience the Power of ONE: Simultaneous Detection of DNA Variants & RNA Fusions in 1-Day Workflow from Sample to Sequencing
Presenters:
George J. Quellhorst, Jr., PhD Associate Director, R&D, QIAGEN;
Andrew Cassidy, PhD, Marketing Project Manager, Enterprise Genomic Services, QIAGEN
QIAGEN — August 20, 2019
Implementation of a Cost-Effective NGS Program in a Laboratory with Limited Resources.
Presenters:
Yassmine Akkari, PhD, Legacy Health
Eva Szarek, PhD, QIAGEN
Invivoscribe — July 23, 2019
Minimal Residual Disease Detection of B-lymphoid and Plasma Cell Neoplasm Using a NGS-Based Clonal IGH Rearrangement Assay
Presenters:
Caleb Ho, MD Memorial Sloan Kettering Cancer Center
Ryan Schmidt, MD, PhD, University of Southern California/Children’s Hospital, Los Angeles
QIAGEN — June 20, 2019
A Pathologist's Guide to Companion Diagnostics and Precision Medicine in Oncology
Presenters: Anjen Chenn, MD, PhD, Sr Director Molecular Diagnostics, LabCorp
Jennifer Quigley, Director Oncology Product Commercialization, LabCorp – Integrated Oncology
Benjamin Chaffey, PhD, Global Product Manager, QIAGEN
Hologic — May 30, 2019
Syndromic Respiratory Testing in a Dynamic Reimbursement Landscape
Presenters:
James Dunn, PhD,Director, Medical Microbiology & Virology Lab, Texas Children’s & Baylor Hospitals
Paul Radensky, MD, JD, Principal, McDermott Consulting
Bristol-Myers Squibb — February 28, 2019
Pathology Leadership in Biomarker Testing: Pre-Analytical Phase
Presenter: Michelle Shiller, DO, Baylor University Medical Center
Beckman Coulter Life Sciences — October 4, 2018
Mutational Signatures in Cytogenetics Risk Groups of Newly Diagnosed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Presenter: Robyn Sussman, PhD, Hospital of the University of Pennsylvania
Moderator: Jung Doh, PhD, Beckman Coulter Life Sciences
RECORDED INDUSTRY SYMPOSIUM PRESENTATION
AMP EUROPE 2018: Achieving Dramatic Insights into Molecular Oncology and Precision Medicine
April 30 to May 2, 2018
Agena Bioscience
Why Liquid Biopsy is Important in Clinical Routine...
Presenter: Ron van Schaik
Rotterdam, The Netherlands
ALK-EML4 Fusions in ctDNA of Lung Cancer Patients in Clinical Practice
Presenter: Antoinette Lemoine
Paris, France
INVIVOSCRIBE — April 17, 2018
Complete Suite of NGS Clonality Assays with Bioinformatics — Identification and Tracking Patient-Specific Clones
Presenters: Presha Shah, PhD and Kasey Hutt, PhD
Invivoscribe, San Diego, CA
View Now
Handout
LymphoTrack Portfolio — MiSeq
LymphoTrack Portfolio — Ion PGM
HOLOGIC — February 22, 2018
Mycoplasma genitalium Infection: An Emerging Sexually Transmitted Infection
Presenter: William M. Geisler MD, MPH
University of Alabama at Birmingham
INVIVOSCRIBE — October 10, 2017
NGS Clonality Testing: Assessing Clonality Status, Somatic Hypermutation and Monitoring Minimum Residual Disease (MRD)
Presenter: Maria Arcila, MD
Moderator: Jeff Miller, PhD
Philips Healthcare IT-Genomics — March 14, 2017
Challenges in Genomic Aberration Detection and Interpretation in Solid Tumors and Evidence-Based Approaches for Targeted Therapy
Presenters: Nevenka Dimitrova, PhD and Sheryl Elkin, PhD
Moderator: Autri Dutta, PhD
Philips Healthcare IT — October 31, 2016
Genetics in Clinical Diagnostics
Presenter: Michael Snyder, PhD
Moderator: Nevenka Dimitrova, PhD
View Now (Audio starts at 1:15)
Handout
ASURAGEN — September 13, 2016
Monitoring Deep Molecular Response: A Sensitive and Robust FDA Cleared Assay for CML
Presenters: Bernard F. Andruss, PhD and Y. Lynn Wang, MD, PhD, FCAP
Moderator: Ninad Pendsé, MBA
Personalis — October 29, 2015
Comprehensive Tumor Characterization Using Augmented NGS
Presenter: Christelle Johnson, PhD
Moderator: Erin Newburn, PhD
Personalis — October 16, 2015
Achieving High Diagnostic Yield for Clinically Relevant Genes: How to ‘ACE' Exome Sequencing
Presenter: Heather Wetzel, MS, LCGC
Moderator: Felicia Hawthorne, PhD
.jpg)
Host a Corporate Workshop
Choose between an in-person workshop at AMP meeting or a live virtual workshop at any point in the year. A limited number of spaces are available.
AMP 2024 Corporate Workshop Recordings
Did you miss corporate workshops at the AMP 2024 Annual Meeting & Expo in Vancouver? Many are now available for streaming. The recordings will be available until November 2025.
